Global Radiopharmaceuticals in Nuclear Medicine Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Nuclear medicine : Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. A Radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Radiopharmaceuticals in Nuclear Medicine market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Radiopharmaceuticals in Nuclear Medicine market are covered in Chapter 9:
Cambridge Isotope Laboratories, Inc.
Board of Radiation And Isotope Technology (BRIT)
Institute of Isotopes Co., Ltd.
GE Healthcare (Subsidiary Of General Electric Company)
Taiyo Nippon Sanso Corporation
Urenco Limited
Institute Of Radioelement (IRE)
Rotem Industries, Ltd., Inc.
Institute of Atomic Energy Polatom Radioisotope Centre
Nordion, Inc.
Fujifilm Holdings Corporation
Lantheus Medical Imaging, Inc.
IBA Group
Ntp Radioisotopes (Pty), Ltd.
Eczacibasi-Monrol
Covidien, Plc
Cardinal Health, Inc.
Siemens Healthcare (Subsidiary Of Siemens AG)
Isotec, Inc. (Sigma-Aldrich)
Australian Nuclear Association And Technology Organization (ANSTO)
Bracco Imaging S.P.A.
In Chapter 5 and Chapter 7.3, based on types, the Radiopharmaceuticals in Nuclear Medicine market from 2017 to 2027 is primarily split into:
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Others
In Chapter 6 and Chapter 7.4, based on applications, the Radiopharmaceuticals in Nuclear Medicine market from 2017 to 2027 covers:
Hospitals
Specialty Clinics
Diagnostic Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Radiopharmaceuticals in Nuclear Medicine market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Radiopharmaceuticals in Nuclear Medicine Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Radiopharmaceuticals in Nuclear Medicine market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Radiopharmaceuticals in Nuclear Medicine market are covered in Chapter 9:
Cambridge Isotope Laboratories, Inc.
Board of Radiation And Isotope Technology (BRIT)
Institute of Isotopes Co., Ltd.
GE Healthcare (Subsidiary Of General Electric Company)
Taiyo Nippon Sanso Corporation
Urenco Limited
Institute Of Radioelement (IRE)
Rotem Industries, Ltd., Inc.
Institute of Atomic Energy Polatom Radioisotope Centre
Nordion, Inc.
Fujifilm Holdings Corporation
Lantheus Medical Imaging, Inc.
IBA Group
Ntp Radioisotopes (Pty), Ltd.
Eczacibasi-Monrol
Covidien, Plc
Cardinal Health, Inc.
Siemens Healthcare (Subsidiary Of Siemens AG)
Isotec, Inc. (Sigma-Aldrich)
Australian Nuclear Association And Technology Organization (ANSTO)
Bracco Imaging S.P.A.
In Chapter 5 and Chapter 7.3, based on types, the Radiopharmaceuticals in Nuclear Medicine market from 2017 to 2027 is primarily split into:
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Others
In Chapter 6 and Chapter 7.4, based on applications, the Radiopharmaceuticals in Nuclear Medicine market from 2017 to 2027 covers:
Hospitals
Specialty Clinics
Diagnostic Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Radiopharmaceuticals in Nuclear Medicine market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Radiopharmaceuticals in Nuclear Medicine Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET OVERVIEW
1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine Market
1.2 Radiopharmaceuticals in Nuclear Medicine Market Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Segment by Application
1.3.1 Radiopharmaceuticals in Nuclear Medicine Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Radiopharmaceuticals in Nuclear Medicine Market, Region Wise (2017-2027)
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.4 China Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.5 Japan Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.6 India Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.8 Latin America Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.5 Global Market Size of Radiopharmaceuticals in Nuclear Medicine (2017-2027)
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Radiopharmaceuticals in Nuclear Medicine Market
2 INDUSTRY OUTLOOK
2.1 Radiopharmaceuticals in Nuclear Medicine Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Radiopharmaceuticals in Nuclear Medicine Market Drivers Analysis
2.4 Radiopharmaceuticals in Nuclear Medicine Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Radiopharmaceuticals in Nuclear Medicine Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Radiopharmaceuticals in Nuclear Medicine Industry Development
3 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET LANDSCAPE BY PLAYER
3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Share by Player (2017-2022)
3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Player (2017-2022)
3.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Player (2017-2022)
3.4 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin by Player (2017-2022)
3.5 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
3.5.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
3.5.2 Radiopharmaceuticals in Nuclear Medicine Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.5 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.6 China Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.7 Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.8 India Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.9 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.10 Latin America Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.11 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Type (2017-2022)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2017-2022)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022)
5.4 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate of Diagnostic Nuclear Medicine (2017-2022)
5.4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate of Therapeutic Nuclear Medicine (2017-2022)
5.4.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION
6.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Application (2017-2022)
6.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Specialty Clinics (2017-2022)
6.3.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Diagnostic Centers (2017-2022)
6.3.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET FORECAST (2022-2027)
7.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast (2022-2027)
7.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Diagnostic Nuclear Medicine (2022-2027)
7.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Therapeutic Nuclear Medicine (2022-2027)
7.3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Others (2022-2027)
7.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Application (2022-2027)
7.4.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Growth Rate of Specialty Clinics(2022-2027)
7.4.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Growth Rate of Diagnostic Centers(2022-2027)
7.4.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Growth Rate of Others(2022-2027)
7.5 Radiopharmaceuticals in Nuclear Medicine Market Forecast Under COVID-19
8 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Radiopharmaceuticals in Nuclear Medicine Analysis
8.6 Major Downstream Buyers of Radiopharmaceuticals in Nuclear Medicine Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Radiopharmaceuticals in Nuclear Medicine Industry
9 PLAYERS PROFILES
9.1 Cambridge Isotope Laboratories, Inc.
9.1.1 Cambridge Isotope Laboratories, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.1.3 Cambridge Isotope Laboratories, Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Board of Radiation And Isotope Technology (BRIT)
9.2.1 Board of Radiation And Isotope Technology (BRIT) Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.2.3 Board of Radiation And Isotope Technology (BRIT) Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Institute of Isotopes Co., Ltd.
9.3.1 Institute of Isotopes Co., Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.3.3 Institute of Isotopes Co., Ltd. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 GE Healthcare (Subsidiary Of General Electric Company)
9.4.1 GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.4.3 GE Healthcare (Subsidiary Of General Electric Company) Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Taiyo Nippon Sanso Corporation
9.5.1 Taiyo Nippon Sanso Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.5.3 Taiyo Nippon Sanso Corporation Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Urenco Limited
9.6.1 Urenco Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.6.3 Urenco Limited Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Institute Of Radioelement (IRE)
9.7.1 Institute Of Radioelement (IRE) Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.7.3 Institute Of Radioelement (IRE) Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Rotem Industries, Ltd., Inc.
9.8.1 Rotem Industries, Ltd., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.8.3 Rotem Industries, Ltd., Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Institute of Atomic Energy Polatom Radioisotope Centre
9.9.1 Institute of Atomic Energy Polatom Radioisotope Centre Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.9.3 Institute of Atomic Energy Polatom Radioisotope Centre Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Nordion, Inc.
9.10.1 Nordion, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.10.3 Nordion, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Fujifilm Holdings Corporation
9.11.1 Fujifilm Holdings Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.11.3 Fujifilm Holdings Corporation Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Lantheus Medical Imaging, Inc.
9.12.1 Lantheus Medical Imaging, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.12.3 Lantheus Medical Imaging, Inc. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 IBA Group
9.13.1 IBA Group Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.13.3 IBA Group Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Ntp Radioisotopes (Pty), Ltd.
9.14.1 Ntp Radioisotopes (Pty), Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.14.3 Ntp Radioisotopes (Pty), Ltd. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Eczacibasi-Monrol
9.15.1 Eczacibasi-Monrol Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.15.3 Eczacibasi-Monrol Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Covidien, Plc
9.16.1 Covidien, Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.16.3 Covidien, Plc Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Cardinal Health, Inc.
9.17.1 Cardinal Health, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.17.3 Cardinal Health, Inc. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Siemens Healthcare (Subsidiary Of Siemens AG)
9.18.1 Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.18.3 Siemens Healthcare (Subsidiary Of Siemens AG) Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Isotec, Inc. (Sigma-Aldrich)
9.19.1 Isotec, Inc. (Sigma-Aldrich) Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.19.3 Isotec, Inc. (Sigma-Aldrich) Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Australian Nuclear Association And Technology Organization (ANSTO)
9.20.1 Australian Nuclear Association And Technology Organization (ANSTO) Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.20.3 Australian Nuclear Association And Technology Organization (ANSTO) Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Bracco Imaging S.P.A.
9.21.1 Bracco Imaging S.P.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.21.3 Bracco Imaging S.P.A. Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine Market
1.2 Radiopharmaceuticals in Nuclear Medicine Market Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Segment by Application
1.3.1 Radiopharmaceuticals in Nuclear Medicine Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Radiopharmaceuticals in Nuclear Medicine Market, Region Wise (2017-2027)
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.4 China Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.5 Japan Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.6 India Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.8 Latin America Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Status and Prospect (2017-2027)
1.5 Global Market Size of Radiopharmaceuticals in Nuclear Medicine (2017-2027)
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Radiopharmaceuticals in Nuclear Medicine Market
2 INDUSTRY OUTLOOK
2.1 Radiopharmaceuticals in Nuclear Medicine Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Radiopharmaceuticals in Nuclear Medicine Market Drivers Analysis
2.4 Radiopharmaceuticals in Nuclear Medicine Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Radiopharmaceuticals in Nuclear Medicine Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Radiopharmaceuticals in Nuclear Medicine Industry Development
3 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET LANDSCAPE BY PLAYER
3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Share by Player (2017-2022)
3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Player (2017-2022)
3.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Player (2017-2022)
3.4 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin by Player (2017-2022)
3.5 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
3.5.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
3.5.2 Radiopharmaceuticals in Nuclear Medicine Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.5 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.6 China Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.7 Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.8 India Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.9 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.10 Latin America Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
4.11 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Type (2017-2022)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2017-2022)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022)
5.4 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate of Diagnostic Nuclear Medicine (2017-2022)
5.4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate of Therapeutic Nuclear Medicine (2017-2022)
5.4.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION
6.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Application (2017-2022)
6.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Specialty Clinics (2017-2022)
6.3.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Diagnostic Centers (2017-2022)
6.3.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET FORECAST (2022-2027)
7.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast (2022-2027)
7.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Diagnostic Nuclear Medicine (2022-2027)
7.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Therapeutic Nuclear Medicine (2022-2027)
7.3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Others (2022-2027)
7.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Application (2022-2027)
7.4.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Growth Rate of Specialty Clinics(2022-2027)
7.4.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Growth Rate of Diagnostic Centers(2022-2027)
7.4.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Growth Rate of Others(2022-2027)
7.5 Radiopharmaceuticals in Nuclear Medicine Market Forecast Under COVID-19
8 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Radiopharmaceuticals in Nuclear Medicine Analysis
8.6 Major Downstream Buyers of Radiopharmaceuticals in Nuclear Medicine Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Radiopharmaceuticals in Nuclear Medicine Industry
9 PLAYERS PROFILES
9.1 Cambridge Isotope Laboratories, Inc.
9.1.1 Cambridge Isotope Laboratories, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.1.3 Cambridge Isotope Laboratories, Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Board of Radiation And Isotope Technology (BRIT)
9.2.1 Board of Radiation And Isotope Technology (BRIT) Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.2.3 Board of Radiation And Isotope Technology (BRIT) Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Institute of Isotopes Co., Ltd.
9.3.1 Institute of Isotopes Co., Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.3.3 Institute of Isotopes Co., Ltd. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 GE Healthcare (Subsidiary Of General Electric Company)
9.4.1 GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.4.3 GE Healthcare (Subsidiary Of General Electric Company) Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Taiyo Nippon Sanso Corporation
9.5.1 Taiyo Nippon Sanso Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.5.3 Taiyo Nippon Sanso Corporation Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Urenco Limited
9.6.1 Urenco Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.6.3 Urenco Limited Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Institute Of Radioelement (IRE)
9.7.1 Institute Of Radioelement (IRE) Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.7.3 Institute Of Radioelement (IRE) Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Rotem Industries, Ltd., Inc.
9.8.1 Rotem Industries, Ltd., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.8.3 Rotem Industries, Ltd., Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Institute of Atomic Energy Polatom Radioisotope Centre
9.9.1 Institute of Atomic Energy Polatom Radioisotope Centre Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.9.3 Institute of Atomic Energy Polatom Radioisotope Centre Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Nordion, Inc.
9.10.1 Nordion, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.10.3 Nordion, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Fujifilm Holdings Corporation
9.11.1 Fujifilm Holdings Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.11.3 Fujifilm Holdings Corporation Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Lantheus Medical Imaging, Inc.
9.12.1 Lantheus Medical Imaging, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.12.3 Lantheus Medical Imaging, Inc. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 IBA Group
9.13.1 IBA Group Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.13.3 IBA Group Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Ntp Radioisotopes (Pty), Ltd.
9.14.1 Ntp Radioisotopes (Pty), Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.14.3 Ntp Radioisotopes (Pty), Ltd. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Eczacibasi-Monrol
9.15.1 Eczacibasi-Monrol Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.15.3 Eczacibasi-Monrol Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Covidien, Plc
9.16.1 Covidien, Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.16.3 Covidien, Plc Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Cardinal Health, Inc.
9.17.1 Cardinal Health, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.17.3 Cardinal Health, Inc. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Siemens Healthcare (Subsidiary Of Siemens AG)
9.18.1 Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.18.3 Siemens Healthcare (Subsidiary Of Siemens AG) Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Isotec, Inc. (Sigma-Aldrich)
9.19.1 Isotec, Inc. (Sigma-Aldrich) Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.19.3 Isotec, Inc. (Sigma-Aldrich) Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Australian Nuclear Association And Technology Organization (ANSTO)
9.20.1 Australian Nuclear Association And Technology Organization (ANSTO) Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.20.3 Australian Nuclear Association And Technology Organization (ANSTO) Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Bracco Imaging S.P.A.
9.21.1 Bracco Imaging S.P.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
9.21.3 Bracco Imaging S.P.A. Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Radiopharmaceuticals in Nuclear Medicine Product Picture
Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and CAGR (%) Comparison by Type
Table Radiopharmaceuticals in Nuclear Medicine Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Radiopharmaceuticals in Nuclear Medicine Industry Development
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Player (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share by Player (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share by Player in 2021
Table Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Player (2017-2022)
Table Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Player (2017-2022)
Table Radiopharmaceuticals in Nuclear Medicine Price by Player (2017-2022)
Table Radiopharmaceuticals in Nuclear Medicine Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Region Wise (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share, Region Wise in 2021
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Region Wise (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, Region Wise (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, Region Wise (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, Region Wise in 2021
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type in 2021
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type in 2021
Table Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate of Diagnostic Nuclear Medicine (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Diagnostic Nuclear Medicine (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate of Therapeutic Nuclear Medicine (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Therapeutic Nuclear Medicine (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Revenue Market Share by Application (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Specialty Clinics (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Diagnostic Centers (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Others (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast (2022-2027)
Figure USA Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Price Forecast, by Type
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Diagnostic Nuclear Medicine (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Diagnostic Nuclear Medicine (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Therapeutic Nuclear Medicine (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Therapeutic Nuclear Medicine (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Consumption Forecast, by Application
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share Forecast, by Application
Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) Forecast, by Application
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast, by Application
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (Million USD) and Growth Rate of Specialty Clinics (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (Million USD) and Growth Rate of Diagnostic Centers (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Cambridge Isotope Laboratories, Inc. Profile
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Cambridge Isotope Laboratories, Inc. Revenue (Million USD) Market Share 2017-2022
Table Board of Radiation And Isotope Technology (BRIT) Profile
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Board of Radiation And Isotope Technology (BRIT) Revenue (Million USD) Market Share 2017-2022
Table Institute of Isotopes Co., Ltd. Profile
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Institute of Isotopes Co., Ltd. Revenue (Million USD) Market Share 2017-2022
Table GE Healthcare (Subsidiary Of General Electric Company) Profile
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure GE Healthcare (Subsidiary Of General Electric Company) Revenue (Million USD) Market Share 2017-2022
Table Taiyo Nippon Sanso Corporation Profile
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Taiyo Nippon Sanso Corporation Revenue (Million USD) Market Share 2017-2022
Table Urenco Limited Profile
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Urenco Limited Revenue (Million USD) Market Share 2017-2022
Table Institute Of Radioelement (IRE) Profile
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Institute Of Radioelement (IRE) Revenue (Million USD) Market Share 2017-2022
Table Rotem Industries, Ltd., Inc. Profile
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Rotem Industries, Ltd., Inc. Revenue (Million USD) Market Share 2017-2022
Table Institute of Atomic Energy Polatom Radioisotope Centre Profile
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Mi
Figure Radiopharmaceuticals in Nuclear Medicine Product Picture
Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and CAGR (%) Comparison by Type
Table Radiopharmaceuticals in Nuclear Medicine Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Radiopharmaceuticals in Nuclear Medicine Industry Development
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Player (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share by Player (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share by Player in 2021
Table Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Player (2017-2022)
Table Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Player (2017-2022)
Table Radiopharmaceuticals in Nuclear Medicine Price by Player (2017-2022)
Table Radiopharmaceuticals in Nuclear Medicine Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Region Wise (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share, Region Wise in 2021
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Region Wise (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, Region Wise (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, Region Wise (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, Region Wise in 2021
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type in 2021
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type in 2021
Table Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate of Diagnostic Nuclear Medicine (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Diagnostic Nuclear Medicine (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate of Therapeutic Nuclear Medicine (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Therapeutic Nuclear Medicine (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Revenue Market Share by Application (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Specialty Clinics (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Diagnostic Centers (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Others (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast (2022-2027)
Figure USA Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Volume Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast, by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Price Forecast, by Type
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Diagnostic Nuclear Medicine (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Diagnostic Nuclear Medicine (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Therapeutic Nuclear Medicine (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Therapeutic Nuclear Medicine (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Consumption Forecast, by Application
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share Forecast, by Application
Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue (Million USD) Forecast, by Application
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast, by Application
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (Million USD) and Growth Rate of Specialty Clinics (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (Million USD) and Growth Rate of Diagnostic Centers (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Cambridge Isotope Laboratories, Inc. Profile
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Cambridge Isotope Laboratories, Inc. Revenue (Million USD) Market Share 2017-2022
Table Board of Radiation And Isotope Technology (BRIT) Profile
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Board of Radiation And Isotope Technology (BRIT) Revenue (Million USD) Market Share 2017-2022
Table Institute of Isotopes Co., Ltd. Profile
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Institute of Isotopes Co., Ltd. Revenue (Million USD) Market Share 2017-2022
Table GE Healthcare (Subsidiary Of General Electric Company) Profile
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure GE Healthcare (Subsidiary Of General Electric Company) Revenue (Million USD) Market Share 2017-2022
Table Taiyo Nippon Sanso Corporation Profile
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Taiyo Nippon Sanso Corporation Revenue (Million USD) Market Share 2017-2022
Table Urenco Limited Profile
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Urenco Limited Revenue (Million USD) Market Share 2017-2022
Table Institute Of Radioelement (IRE) Profile
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Institute Of Radioelement (IRE) Revenue (Million USD) Market Share 2017-2022
Table Rotem Industries, Ltd., Inc. Profile
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate
Figure Rotem Industries, Ltd., Inc. Revenue (Million USD) Market Share 2017-2022
Table Institute of Atomic Energy Polatom Radioisotope Centre Profile
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue (Mi
